The trademark application ImmuneCytonin was filed by S.A.R.L. AXEEN PHARMA, a corporation established under the laws of the Principality of Monaco (the "Applicant"). The application was published for oppositions on March 4, 2021, and it was registered by office on June 11, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on May 13, 2021. A transfer of the trademark registration was recorded on November 4, 2021.